Back to search

Japan· JP-6428001F1012

ジエチルカルバマジンクエン酸塩

A diethylcarbamazine product containing ジエチルカルバマジンクエン酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 4 of our 19 countries.

On Japan’s NHI price listATC P02CB02

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedジエチルカルバマジンクエン酸塩ATCP02CB02REGISTER NO.JP-6428001F1012PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Diethylcarbamazine is registered in 4 of 19 countries.

Countries holding a registration under ATC P02CB02 (diethylcarbamazine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 2 of them publish a price we can compare per daily dose

Diethylcarbamazine · ATC P02CB02

4 / 19 countries

  • Franceprice
  • Japan
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

MHLW / PMDA (Japan)
Active substance
ジエチルカルバマジンクエン酸塩
Manufacturer
—
Country
Japan (JP)
ATC code
P02CB02
ATC class
Diethylcarbamazine
Defined daily dose
0.4 g, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c73f088e-bdfb-4044-9f9d-d49be90b716a
GET /v1/drugs/c73f088e-bdfb-4044-9f9d-d49be90b716a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "50mg1錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "6428001F1012",
  "category": "内用薬",
  "price_yen": null,
  "generic_name": "ジエチルカルバマジンクエン酸塩",
  "product_name_jp": null,
  "therapeutic_class": "6428",
  "transitional_expiry": null
}

See everything about diethylcarbamazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.